Treatment of Morbihan disease
Archives of Craniofacial Surgery
;
: 131-134, 2021.
Article
in English
| WPRIM
| ID: wpr-889372
ABSTRACT
Morbihan disease (MD) is a rare condition that involves rosaceous lymphedema or erythematous lymphedema of the middle and upper thirds of the face. It typically affects the periorbital region, forehead, glabella, nose, and cheeks. The etiology of MD remains unclear, and its diagnosis is challenging. MD often tends to be unresponsive to therapies commonly used to treat rosacea, including corticosteroids, isotretinoin, and antibiotics. Surgical treatments have therefore been attempted, but most cases showed unsatisfactory responses. These problems could have resulted from an incorrect recognition and interpretation of the pathophysiology of MD and inaccurate planning of the operation, resulting in recurrence or exacerbation of edema.
Full text:
Available
Index:
WPRIM (Western Pacific)
Language:
English
Journal:
Archives of Craniofacial Surgery
Year:
2021
Type:
Article
Similar
MEDLINE
...
LILACS
LIS